| Dr Andrew Albert Peterson, MD | |
|
190 E Bannock St, Boise, ID 83712-6241 | |
| (208) 381-2094 | |
| (208) 381-1791 |
| Full Name | Dr Andrew Albert Peterson |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 15 Years |
| Location | 190 E Bannock St, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083842033 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | M-13255 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| St Luke's Nampa Medical Center | Nampa, ID | Hospital |
| St Luke's Wood River Medical Center | Ketchum, ID | Hospital |
| St Luke's Elmore Medical Center | Mountain home, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boise Radiology Group Pllc | 9638153257 | 53 |
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
A 30-year-old woman with a history of upper respiratory infections had no idea she carried an immunodeficiency disorder - until her 6-year-old son was diagnosed with the same illness.
Eli Lilly and Company today announced it will begin enrolling patients in a second Phase III study of LY450139, a gamma-secretase inhibitor being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been selected as the National Children's Study (NCS) biological and environmental sample repository partner. The study examines the effects of environmental influences on the health and development of 100,000 children across the United States, following them from before birth until age 21.
Hispanic children are less likely to be diagnosed with attention deficit and hyperactivity disorder during primary care visits than white or black children are, according to a new study that looks at children's physician visits nationwide.
› Verified 3 days ago
| Entity Name | Boise Radiology Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740216175 PECOS PAC ID: 9638153257 Enrollment ID: O20040614000277 |
News Archive
A 30-year-old woman with a history of upper respiratory infections had no idea she carried an immunodeficiency disorder - until her 6-year-old son was diagnosed with the same illness.
Eli Lilly and Company today announced it will begin enrolling patients in a second Phase III study of LY450139, a gamma-secretase inhibitor being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been selected as the National Children's Study (NCS) biological and environmental sample repository partner. The study examines the effects of environmental influences on the health and development of 100,000 children across the United States, following them from before birth until age 21.
Hispanic children are less likely to be diagnosed with attention deficit and hyperactivity disorder during primary care visits than white or black children are, according to a new study that looks at children's physician visits nationwide.
› Verified 3 days ago
| Entity Name | Weiser Valley Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255364030 PECOS PAC ID: 5294704276 Enrollment ID: O20050124000126 |
News Archive
A 30-year-old woman with a history of upper respiratory infections had no idea she carried an immunodeficiency disorder - until her 6-year-old son was diagnosed with the same illness.
Eli Lilly and Company today announced it will begin enrolling patients in a second Phase III study of LY450139, a gamma-secretase inhibitor being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been selected as the National Children's Study (NCS) biological and environmental sample repository partner. The study examines the effects of environmental influences on the health and development of 100,000 children across the United States, following them from before birth until age 21.
Hispanic children are less likely to be diagnosed with attention deficit and hyperactivity disorder during primary care visits than white or black children are, according to a new study that looks at children's physician visits nationwide.
› Verified 3 days ago
| Entity Name | North Canyon Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609046671 PECOS PAC ID: 0941371439 Enrollment ID: O20090409000304 |
News Archive
A 30-year-old woman with a history of upper respiratory infections had no idea she carried an immunodeficiency disorder - until her 6-year-old son was diagnosed with the same illness.
Eli Lilly and Company today announced it will begin enrolling patients in a second Phase III study of LY450139, a gamma-secretase inhibitor being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been selected as the National Children's Study (NCS) biological and environmental sample repository partner. The study examines the effects of environmental influences on the health and development of 100,000 children across the United States, following them from before birth until age 21.
Hispanic children are less likely to be diagnosed with attention deficit and hyperactivity disorder during primary care visits than white or black children are, according to a new study that looks at children's physician visits nationwide.
› Verified 3 days ago
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
A 30-year-old woman with a history of upper respiratory infections had no idea she carried an immunodeficiency disorder - until her 6-year-old son was diagnosed with the same illness.
Eli Lilly and Company today announced it will begin enrolling patients in a second Phase III study of LY450139, a gamma-secretase inhibitor being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been selected as the National Children's Study (NCS) biological and environmental sample repository partner. The study examines the effects of environmental influences on the health and development of 100,000 children across the United States, following them from before birth until age 21.
Hispanic children are less likely to be diagnosed with attention deficit and hyperactivity disorder during primary care visits than white or black children are, according to a new study that looks at children's physician visits nationwide.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Albert Peterson, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: (208) 381-2094 | Dr Andrew Albert Peterson, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: (208) 381-2094 |
News Archive
A 30-year-old woman with a history of upper respiratory infections had no idea she carried an immunodeficiency disorder - until her 6-year-old son was diagnosed with the same illness.
Eli Lilly and Company today announced it will begin enrolling patients in a second Phase III study of LY450139, a gamma-secretase inhibitor being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been selected as the National Children's Study (NCS) biological and environmental sample repository partner. The study examines the effects of environmental influences on the health and development of 100,000 children across the United States, following them from before birth until age 21.
Hispanic children are less likely to be diagnosed with attention deficit and hyperactivity disorder during primary care visits than white or black children are, according to a new study that looks at children's physician visits nationwide.
› Verified 3 days ago
Jeffrey T Seabourn, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2161 | |
Caroline D Sobota, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2161 | |
Dr. Chad Eric Sarver, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Mr. Jesse W Spinner, MD Radiology Medicare: Medicare Enrolled Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2121 Fax: 706-596-6720 | |
Brian Lane Mcmahan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2094 Fax: 208-381-1791 | |
Craig E Leymaster, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2094 | |
John A Jackson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2161 |